公开(公告)号：US20230174512A1

公开(公告)日：2023-06-08

申请号：US17922804

申请日：2021-05-04

Applicant: QILU REGOR THERAPEUTICS INC.

Inventor： Zhilong Hu ,  Hu He ,  Fei Zhang ,  Wenge Zhong ,  Xiaotian Zhu

IPC: C07D401/14 ,  A61K45/06 ,  A61P35/00

CPC classification number: C07D401/14 ,  A61K45/06 ,  A61P35/00

Abstract: The invention provides a compound represented by the following structural formula: (I) or a pharmaceutically acceptable salt, or a stereoisomer thereof useful for treating cancer.

公开(公告)号：US20240066031A1

公开(公告)日：2024-02-29

申请号：US18373060

申请日：2023-09-26

Applicant: QILU REGOR THERAPEUTICS INC.

Inventor： Zhilong Hu ,  Hu He ,  Fei Zhang ,  Wenge Zhong ,  Xiaotian Zhu

IPC: A61K31/506 ,  A61K31/5377 ,  A61K31/55 ,  A61K45/06 ,  A61P35/00 ,  C07D401/14 ,  C07D405/14 ,  C07D487/04

CPC classification number: A61K31/506 ,  A61K31/5377 ,  A61K31/55 ,  A61K45/06 ,  A61P35/00 ,  C07D401/14 ,  C07D405/14 ,  C07D487/04

Abstract: The invention provides a compound represented by the following structural formula: (I) or a pharmaceutically acceptable salt, or a stereoisomer thereof useful for treating cancer.

公开(公告)号：US20240033264A1

公开(公告)日：2024-02-01

申请号：US18373067

申请日：2023-09-26

Applicant: QILU REGOR THERAPEUTICS INC.

Inventor： Zhilong Hu ,  Hu He ,  Fei Zhang ,  Wenge Zhong ,  Xiaotian Zhu

IPC: A61K31/506 ,  A61P35/00 ,  A61K31/5377 ,  A61K31/55 ,  C07D405/14 ,  C07D487/04 ,  A61K45/06 ,  C07D401/14

CPC classification number: A61K31/506 ,  A61P35/00 ,  A61K31/5377 ,  A61K31/55 ,  C07D405/14 ,  C07D487/04 ,  A61K45/06 ,  C07D401/14

Abstract: The invention provides a compound represented by the following structural formula: (I) or a pharmaceutically acceptable salt, or a stereoisomer thereof useful for treating cancer.

公开(公告)号：US20220296595A1

公开(公告)日：2022-09-22

申请号：US17608915

申请日：2020-05-05

Applicant: QILU REGOR THERAPEUTICS INC.

Inventor： Zhilong Hu ,  Hu He ,  Fei Zhang ,  Xiaotian Zhu ,  Wenge Zhong

IPC: A61K31/506 ,  A61K31/5377 ,  A61K31/55 ,  A61P35/00 ,  C07D405/14 ,  C07D487/04

Abstract: Provided is a compound represented by structural formula (I), or a pharmaceutically acceptable salt, or a stereoisomer thereof useful for treating cancer.